Effect of Structured Non-Pharmacological Counselling on Migraine-Related Disability and Quality of Life: A Randomised Interventional Cohort Study in a Tertiary Care Hospital.
Abstract Background Migraine can cause substantial disability and reduce everyday functioning. Structured counselling on lifestyle and self-management may complement pharmacological treatment, but local evidence on its effects on disability and migraine-specific quality-of-life measures remains limited. Objective To assess the effect of structured non-pharmacological counselling added to pharmacological treatment on migraine-related disability and migraine-specific quality-of-life measures among adult patients attending a tertiary care hospital. Methods This Randomised Interventional Cohort Study included 60 adults with migraine recruited from the Neurology inpatient and outpatient services at KMCH, Coimbatore, from April to September 2026. Participants were allocated to a control group receiving pharmacological treatment alone (n = 30) or an intervention group receiving pharmacological treatment plus one-to-one structured counselling (n = 30). Allocation followed the recruitment week: weeks 1 and 3 were assigned to the intervention group and weeks 2 and 4 to the control group. Outcomes were assessed at baseline and 2 months using the Migraine Disability Assessment (MIDAS) and recorded MSQ V2.1 domain scores. Within-group change, between-group change, baseline-adjusted follow-up MIDAS, and a 50% MIDAS responder analysis were evaluated. Results Mean baseline MIDAS scores were 19.67 ± 7.55 in controls and 24.43 ± 17.38 in the intervention group (p = 0.441). Scores decreased in both groups at 2 months: by 2.63 ± 2.80 points in controls (19.67 ± 7.55 to 17.03 ± 6.04; p < 0.001) and by 5.67 ± 5.49 points in the intervention group (24.43 ± 17.38 to 18.77 ± 12.76; p < 0.001). The between-group difference in MIDAS reduction was significant (Mann-Whitney U = 280.000; Z=-2.531; p = 0.011), as was the group effect after baseline adjustment (F (1,57) = 7.894; p = 0.007). A reduction of at least 50% occurred in one intervention participant and no controls (p = 1.000). Several recorded MSQ-coded domains changed statistically, but their interpretation as validated MSQ V2.1 quality-of-life scores remains uncertain because scoring requires verification. Conclusion Adding structured non-pharmacological counselling to pharmacological care was associated with a greater reduction in MIDAS scores over 2 months than pharmacological care alone. The responder analysis was not significant, and quality-of-life findings should be interpreted cautiously until the MSQ scoring is confirmed.
Authors
- Jayalakshmi Venugopal (ORCID: https://orcid.org/0009-0005-5690-971X)
- Shalini
- Vasanthan
Institutions
- Kannur Medical College (IN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-11702687/v1
- Primary Topic
- Migraine and Headache Studies
- Type
- preprint